ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Liothyronine Sodium tablets 5mcg and 20mcg

Strides Pharma UK Ltd has informed MHRA of an error in the patient information leaflet (PIL) for Liothyronine Sodium 20 micrograms Tablets and Liothyronine Sodium 5 micrograms Tablets.

 

MHRA Drug alert date: 28th November 2024

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strides-pharma-uk-ltd-liothyronine-sodium-5-and-20-micrograms-tablets-el-24-a-slash-58?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=1b6cc57b-c4b2-4d42-b911-de0ebf43fd1b&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

1234939

LIOTHYRONINE SOD TAB 5MCG    

Strides Pharma

EH24LIE001

8384919

LIOTHYRONINE SOD TAB 20MCG

Strides Pharma

EH23LIF004 EH24LIF001

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information enquiries please contact Strides Pharma UK Ltd via email dl-drugsafety@strides.com or telephone +919844460742

 

For stock control enquiries please contact Strides Pharma UK Ltd via email customerservicesuk@stridespharma.co.uk or telephone 01923 255580